Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 23;42(5):175.
doi: 10.1007/s12032-025-02724-2.

Promising immunotherapeutic treatments for colon cancer

Arturo G Gutiu #  1 , Lei Zhao #  2 , Austin J Marrah  3 , Austin J Maher  3 , Brady B Voss  3 , Trenton G Mayberry  3 , Braydon C Cowan  3 , Mark R Wakefield  3   4 , Yujiang Fang  5   6   7   8
Affiliations
Review

Promising immunotherapeutic treatments for colon cancer

Arturo G Gutiu et al. Med Oncol. .

Abstract

Colon cancer continues to predominate as one of the most common causes of morbidity and mortality worldwide due to its subtle symptomology and multifactorial etiology. Currently, the standard treatment approach involves surgical resection for localized tumors and adjuvant chemotherapy (AC) for cancers that have spread or invaded locally. Unfortunately, this treatment strategy may not be effective for advanced, metastatic stages of the disease or in instances of recurrence. However, advancements in immunotherapy have demonstrated promising results in the field of medical oncology, which could redefine the way patients and clinicians view the disease. These treatments have shown benefit and have the potential to be superior to the current interventions available for afflicted patients. The application of immunotherapy in conjunction with traditional treatments may improve the outcomes of patients suffering from colon cancer and decrease the burden this disease has on patients. Furthermore, more effective treatments in the form of conjunction immunological, surgical, and chemotherapeutic techniques may shorten treatment courses and lead to better long-term effects. This review paper investigates immunotherapeutic interventions for colon cancer, which include immune checkpoint inhibitors, oncolytic virotherapy, cancer vaccines, cytokine therapy, and CAR-T. Such a study might provide more information for clinicians to treat patients with colon cancer in the advanced stages or in recurrence.

Keywords: Colon cancer; Treatment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Disclosure: The authors have no disclosures.

References

    1. Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, De Braud F, Wils J. Colon cancer. Crit Rev Oncol Hematol. 2010;74(2):106–33. https://doi.org/10.1016/j.critrevonc.2010.01.010 . - DOI - PubMed
    1. “Cancer of the Colon and Rectum - Cancer Stat Facts.” SEER, National Cancer Institute, https://seer.cancer.gov/statfacts/html/colorect.html
    1. Rassy E, Parent P, Lefort F, Boussios S, Baciarello G, Pavlidis N. New rising entities in cancer of unknown primary: is there a real therapeutic benefit? Crit Rev Oncol Hematol. 2020;147:2–3. https://doi.org/10.1016/j.critrevonc.2020.102882 . - DOI
    1. Aghabozorgi AS, Bahreyni A, Soleimani A, Bahrami A, Khazaei M, Ferns GA, Avan A, Hassanian SM. Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and Perspectives. Biochimie. 2019;157:64–71. https://doi.org/10.1016/j.biochi.2018.11.003 . - DOI - PubMed
    1. Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J. 2012;31(12):2714–36. https://doi.org/10.1038/emboj.2012.150 . - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources